Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Medifast (MED) Accumulated Depreciation & Amortization (2016 - 2025)

Medifast (MED) has disclosed Accumulated Depreciation & Amortization for 16 consecutive years, with $14.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 12.08% year-over-year to $14.2 million, compared with a TTM value of $14.2 million through Dec 2025, up 12.08%, and an annual FY2025 reading of $14.2 million, up 12.08% over the prior year.
  • Accumulated Depreciation & Amortization was $14.2 million for Q4 2025 at Medifast, up from $12.7 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $14.2 million in Q4 2025 and bottomed at $6.8 million in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $11.6 million, with a median of $12.7 million recorded in 2024.
  • The sharpest move saw Accumulated Depreciation & Amortization soared 61.19% in 2022, then decreased 3.05% in 2024.
  • Year by year, Accumulated Depreciation & Amortization stood at $6.8 million in 2021, then skyrocketed by 61.19% to $11.0 million in 2022, then increased by 19.37% to $13.1 million in 2023, then dropped by 3.05% to $12.7 million in 2024, then increased by 12.08% to $14.2 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for MED at $14.2 million in Q4 2025, $12.7 million in Q4 2024, and $13.1 million in Q4 2023.